ELV
Elevance Health, Inc.
$429.69−0.21 (−0.05%)Close Nov 13, 2026
Insider trading
12 months to Nov 6, 2026- Net sold
- $4.74M
- Sales less buys
- Bought
- $2.24M
- 3 insiders
- Sold
- $6.98M
- 6 insiders
- Latest buy
- Jul 17, 2026
- Gail Boudreaux
Buys and sales on the price
Since 2003By period
Open-market trades| Trades | 3 months | 12 months | Since 2003 |
|---|---|---|---|
| Buys | 0 | 3 | 14 |
| Sales | 2 | 7 | 527 |
| Plan sales | 0 | 0 | 212 |
| Shares bought | 00 | 6,7256.72K | 30,08030.1K |
| Shares sold | 11,88411.9K | 17,15717.2K | 15,621,66415.6M |
| Net shares | −11,884−11.9K | −10,432−10.4K | −15,591,584−15.6M |
| Net value | −$5.23M | −$4.74M | −$1.32B |
Insiders
| Insider | 12 months | Shares held |
|---|---|---|
Gail Boudreaux President and CEO, Director | +1.8% | 172,036 |
Felicia F. Norwood EVP &Chief Health Benefits Ofr | — | 38,838 as of Mar 4, 2026 |
Peter D. Haytaian EVP & Pres Carelon & CarelonRx | — | 27,222 as of Mar 4, 2026 |
Mark Kaye EVP & CFO | −65.8% | 19,919 |
Ratnakar Lavu EVP & Chief Digital Info Ofr | −27.2% | 14,849 |
Trades
541 trades since 2003| Type | Insider | Role | Shares | Price | Held after | |||
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | Sale | Ratnakar LavuEVP & Chief Digital Info Ofr EVP & Chief Digital Info Ofr | EVP & Chief Digital Info Ofr | 1,300 at $440.00 | $440.00 | $572K | −8.1% 14.8K after | 14,849 |
| Oct 22, 2026 | Sale | Mark KayeEVP & CFO EVP & CFO | EVP & CFO | 10,584 at $440.13 | $440.13 | $4.66M | −34.7% 19.9K after | 19,919 |
| Jul 17, 2026 | Buy | Gail BoudreauxPresident and CEO, Director President and CEO, Director | President and CEO, Director | 2,725 at $367.79 | $367.79 | $1.00M | +1.6% 172K after | 172,036 |
| Jul 17, 2026 | Buy | Ramiro G. PeruDirector Director | Director | 1,000 at $366.05 | $366.05 | $366K | +10.1% 10.9K after | 10,908 |
| Jun 12, 2026 | Sale | Ronald W. PenczekCAO & Controller CAO & Controller | CAO & Controller | 369 at $403.16 | $403.16 | $149K | −9.0% 3.74K after | 3,740 |
| Jun 11, 2026 | Sale | Robert L. Dixon JRDirector Director | Director | 151 at $401.77 | $401.77 | $60.7K | −1.4% 10.7K after | 10,734 |
| May 19, 2026 | Sale | Ronald W. PenczekCAO & Controller CAO & Controller | CAO & Controller | 1,531 at $403.13 | $403.13 | $617K | −27.1% 4.11K after | 4,109 |
| Mar 12, 2026 | Sale | Amy W. SchulmanDirector Director | Director | 26 at $287.50 | $287.50 | $7.47K | −10.7% 218 after | 218 |
| Mar 6, 2026 | Sale | Charles Morgan Kendrick JREVP & President, Commercial EVP & President, Commercial | EVP & President, Commercial | 3,196 at $284.92 | $284.92 | $911K | −21.3% 11.8K after | 11,791 |
| Mar 5, 2026 | Buy | Steven H. CollisDirector Director | Director | 3,000 at $289.84 | $289.84 | $870K | +469.5% 3.64K after | 3,639 |
- Ratnakar Lavu$572KNov 5, 2026 · Sale1,300 at $440.00EVP & Chief Digital Info Ofr−8.1% of holdings, 14.8K after
- Mark Kaye$4.66MOct 22, 2026 · Sale10,584 at $440.13EVP & CFO−34.7% of holdings, 19.9K after
- Gail Boudreaux$1.00MJul 17, 2026 · Buy2,725 at $367.79President and CEO, Director+1.6% of holdings, 172K after
- Ramiro G. Peru$366KJul 17, 2026 · Buy1,000 at $366.05Director+10.1% of holdings, 10.9K after
- Ronald W. Penczek$149KJun 12, 2026 · Sale369 at $403.16CAO & Controller−9.0% of holdings, 3.74K after
- Robert L. Dixon JR$60.7KJun 11, 2026 · Sale151 at $401.77Director−1.4% of holdings, 10.7K after
- Ronald W. Penczek$617KMay 19, 2026 · Sale1,531 at $403.13CAO & Controller−27.1% of holdings, 4.11K after
- Amy W. Schulman$7.47KMar 12, 2026 · Sale26 at $287.50Director−10.7% of holdings, 218 after
- Charles Morgan Kendrick JR$911KMar 6, 2026 · Sale3,196 at $284.92EVP & President, Commercial−21.3% of holdings, 11.8K after
- Steven H. Collis$870KMar 5, 2026 · Buy3,000 at $289.84Director+469.5% of holdings, 3.64K after